Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
In Vitro DiagnosticsCancerCancer Diagnostic

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1223483

Cover Image

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1223483

APAC Thyroid Cancer Diagnostics Market - Industry Trends and Forecast to 2030

PUBLISHED:
PAGES: 260 Pages
DELIVERY TIME: Inquiry
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License) - Printable/Downloadable
USD 3500
PDF (Enterprise License) - Printable/Downloadable
USD 4200

Add to Cart

Description

Table of Contents

List of Tables

The Asia-Pacific thyroid cancer diagnostics market is projected to register a substantial CAGR of 5.0% from 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.

Market Segmentation:

Asia-Pacific Thyroid Cancer Diagnostics Market, By Product Type (Instruments, Consumables & Accessories), Test Type (Imaging Test, Blood Test, Biopsy, Others), Cancer Type (Papillary Carcinoma, Follicular Carcinoma, Others), Stages (Stage I, Stage II, Stage III, Stage IV), Age Group (30-65, 65 and Above, 21-29, Below 21), End Users (Hospital, Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes, Others), Distribution Channel (Direct Tender, Retail Sales), Country (China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific) Industry Trends and Forecast to 2030.

Some of the major factors contributing to the growth of the Asia-Pacific thyroid cancer diagnostics market are:

Rising incidence and prevalence of thyroid nodules and cancer

Rising thyroid cancer diagnostic tests rise in product approvals

Market Players:

Some of the major players operating in the Asia-Pacific thyroid cancer diagnostics market are:

F. Hoffmann-La Roche Ltd

Quest Diagnostics Incorporated

Illumina, Inc.

Koninklijke Philips N.V.

Thermo Fisher Scientific Inc.

Siemens Healthcare GmbH

Abbott

BD

QIAGEN

Merck KGaA

Hologic Inc.

Myriad Genetics, Inc.

Time Medical Holding.

PlexBio

Beijing O&D Biotech Co., Ltd.

Show more

TABLE OF CONTENTS

1 INTRODUCTION 46

  • 1.1 OBJECTIVES OF THE STUDY 46
  • 1.2 MARKET DEFINITION 46
  • 1.3 OVERVIEW OF THE ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET 46
  • 1.4 LIMITATIONS 48
  • 1.5 MARKETS COVERED 48

2 MARKET SEGMENTATION 51

  • 2.1 MARKETS COVERED 51
  • 2.2 GEOGRAPHICAL SCOPE 52
  • 2.3 YEARS CONSIDERED FOR THE STUDY 53
  • 2.4 CURRENCY AND PRICING 53
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL 54
  • 2.6 MULTIVARIATE MODELLING 57
  • 2.7 PRODUCT TYPE LIFELINE CURVE 57
  • 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 58
  • 2.9 DBMR MARKET POSITION GRID 59
  • 2.10 MARKET TESTING TYPE COVERAGE GRID 61
  • 2.11 VENDOR SHARE ANALYSIS 62
  • 2.12 SECONDARY SOURCES 63
  • 2.13 ASSUMPTIONS 63

3 EXECUTIVE SUMMARY 64

4 PREMIUM INSIGHTS 67

  • 4.1 PESTEL ANALYSIS 68
  • 4.2 PORTER'S FIVE FORCES 69
  • 4.3 GROWTH STRATEGIES ADOPTED BY KEY MARKET PLAYERS 70

5 EPIDEMIOLOGY 71

6 REGULATORY FRAMEWORK OF THE ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET 72

  • 6.1 REGULATORY SCENARIO IN THE U.S. 72
  • 6.2 REGULATORY SCENARIO IN AUSTRALIA 73
  • 6.3 REGULATORY SCENARIO IN JAPAN 73
  • 6.4 REGULATORY SCENARIO IN CHINA 73

7 MARKET OVERVIEW 74

  • 7.1 DRIVERS 76
    • 7.1.1 RISING INCIDENCE AND PREVALENCE OF THYROID NODULES AND CANCER 76
    • 7.1.2 RISING THYROID CANCER DIAGNOSTIC TESTS 76
    • 7.1.3 RISING PREFERENCE FOR PREVENTIVE HEALTH CHECK-UPS 77
    • 7.1.4 RISING AWARENESS TOWARDS THYROID CANCER 77
  • 7.2 RESTRAINTS 78
    • 7.2.1 HIGH COST OF DIAGNOSTICS PROCEDURE 78
    • 7.2.2 TISSUE DAMAGE DUE TO HIGH RADIATION EXPOSURE FROM IMAGING TESTS 79
  • 7.3 OPPORTUNITIES 79
    • 7.3.1 RISE IN HEALTHCARE EXPENDITURE FOR CANCER DIAGNOSIS AND TREATMENT 79
    • 7.3.2 RISING OBESE POPULATION 80
  • 7.4 CHALLENGES 80
    • 7.4.1 STRINGENT REGULATORY FRAMEWORK FOR THE APPROVAL AND COMMERCIALIZATION OF CANCER DIAGNOSTIC PRODUCTS 80
    • 7.4.2 LACK OF SKILLED AND CERTIFIED EXPERTISE 81

8 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE 82

  • 8.1 OVERVIEW 83
  • 8.2 INSTRUMENTS 86
    • 8.2.1 PATHOLOGY BASED INSTRUMENTS 87
      • 8.2.1.1 PCR INSTRUMENTS 87
      • 8.2.1.2 SLIDE STAINING SYSTEMS 87
      • 8.2.1.3 TISSUE PROCESSING SYSTEMS 87
      • 8.2.1.4 CELL PROCESSORS 88
      • 8.2.1.5 OTHER PATHOLOGY-BASED INSTRUMENTS 88
    • 8.2.2 IMAGING INSTRUMENTS 88
      • 8.2.2.1 ULTRASOUND SYSTEMS 88
      • 8.2.2.2 CT SYSTEMS 88
      • 8.2.2.3 MRI SYSTEMS 88
      • 8.2.2.4 OTHERS 88
    • 8.2.3 BIOPSY INSTRUMENTS 89
      • 8.2.3.1 NEEDLE BIOPSY 89
      • 8.2.3.2 ENDOSCOPIC BIOPSY 89
      • 8.2.3.3 CORE BIOPSY 89
      • 8.2.3.4 OTHERS 89
    • 8.2.4 OTHERS 89
  • 8.3 CONSUMABLES & ACCESSORIES 90
    • 8.3.1 KITS 91
      • 8.3.1.1 PCR KITS 91
      • 8.3.1.2 DNA POLYMERASE KITS 91
      • 8.3.1.3 NUCLEIC ACID ISOLATION KITS 91
      • 8.3.1.4 OTHERS 91
    • 8.3.2 REAGENTS 92
      • 8.3.2.1 ASSAYS 92
      • 8.3.2.2 BUFFERS 92
      • 8.3.2.3 PRIMERS 92
      • 8.3.2.4 OTHERS 92
    • 8.3.3 PROBES 92
    • 8.3.4 OTHER CONSUMABLES 92

9 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE 93

  • 9.1 OVERVIEW 94
  • 9.2 IMAGING TEST 97
    • 9.2.1 COMPUTED TOMOGRAPHY (CT) SCAN 98
    • 9.2.2 MRI 98
    • 9.2.3 POSITRON EMISSION TOMOGRAPHY (PET) SCAN 98
    • 9.2.4 OTHERS 98
  • 9.3 BLOOD TEST 99
    • 9.3.1 BLOOD CHEMISTRY TESTS 100
    • 9.3.2 COMPLETE BLOOD COUNT (CBC) 100
    • 9.3.3 OTHERS 100
  • 9.4 BIOPSY 100
    • 9.4.1 NEEDLE BIOPSY 101
    • 9.4.2 BRONCHOSCOPY BIOPSY 101
    • 9.4.3 CORE BIOPSY 101
    • 9.4.4 OTHERS 101
  • 9.5 OTHERS 102

10 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET, BY CANCER TYPE 103

  • 10.1 OVERVIEW 104
  • 10.2 PAPILLARY CARCINOMA 107
  • 10.3 FOLLICULAR CARCINOMA 108
  • 10.4 OTHERS 109

11 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET, BY STAGES 110

  • 11.1 OVERVIEW 111
  • 11.2 STAGE I 114
  • 11.3 STAGE II 115
  • 11.4 STAGE III 116
  • 11.5 STAGE IV 117

12 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET, BY AGE GROUP 118

  • 12.1 OVERVIEW 119
  • 12.2 30-65 122
  • 12.3 65 AND ABOVE 123
  • 12.4 21-29 124
  • 12.5 BELOW 21 125

13 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET, BY END USER 126

  • 13.1 OVERVIEW 127
  • 13.2 HOSPITALS 130
  • 13.3 ASSOCIATED LABS 131
  • 13.4 INDEPENDENT DIAGNOSTIC LABORATORIES 131
  • 13.5 DIAGNOSTIC IMAGING CENTERS 132
  • 13.6 CANCER RESEARCH INSTITUTES 133
  • 13.7 OTHERS 134

14 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL 135

  • 14.1 OVERVIEW 136
  • 14.2 DIRECT TENDER 139
  • 14.3 RETAIL SALES 140

15 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET, BY REGION 141

  • 15.1 ASIA-PACIFIC 142
    • 15.1.1 JAPAN 152
    • 15.1.2 CHINA 157
    • 15.1.3 SOUTH KOREA 163
    • 15.1.4 INDIA 168
    • 15.1.5 THAILAND 173
    • 15.1.6 SINGAPORE 178
    • 15.1.7 INDONESIA 183
    • 15.1.8 MALAYSIA 188
    • 15.1.9 PHILIPPINES 193
    • 15.1.10 AUSTRALIA 199
    • 15.1.11 VIETNAM 204
    • 15.1.12 REST OF ASIA-PACIFIC 209

16 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET: COMPANY LANDSCAPE 210

  • 16.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC 210

17 SWOT ANALYSIS 211

18 COMPANY PROFILE 212

  • 18.1 CANON INC. 212
    • 18.1.1 COMPANY SNAPSHOT 212
    • 18.1.2 COMPANY SHARE ANALYSIS 212
    • 18.1.3 PRODUCT PORTFOLIO 213
    • 18.1.4 RECENT DEVELOPMENTS 213
  • 18.2 FUJIFILM CORPORATION 214
    • 18.2.1 COMPANY SNAPSHOT 214
    • 18.2.2 REVENUE ANALYSIS 214
    • 18.2.3 COMPANY SHARE ANALYSIS 215
    • 18.2.4 PRODUCT PORTFOLIO 215
    • 18.2.5 RECENT DEVELOPMENT 215
  • 18.3 F. HOFFMANN-LA ROCHE LTD 216
    • 18.3.1 COMPANY SNAPSHOT 216
    • 18.3.2 REVENUE ANALYSIS 216
    • 18.3.3 COMPANY SHARE ANALYSIS 217
    • 18.3.4 PRODUCT PORTFOLIO 217
    • 18.3.5 RECENT DEVELOPMENT 217
  • 18.4 QUEST DIAGNOSTICS INCORPORATED 218
    • 18.4.1 COMPANY SNAPSHOT 218
    • 18.4.2 REVENUE ANALYSIS 218
    • 18.4.3 COMPANY SHARE ANALYSIS 219
    • 18.4.4 PRODUCT PORTFOLIO 219
    • 18.4.5 RECENT DEVELOPMENTS 219
  • 18.5 ILLUMINA, INC. 221
    • 18.5.1 COMPANY SNAPSHOT 221
    • 18.5.2 REVENUE ANALYSIS 221
    • 18.5.3 COMPANY SHARE ANALYSIS 222
    • 18.5.4 PRODUCT PORTFOLIO 222
    • 18.5.5 RECENT DEVELOPMENT 222
  • 18.6 ABBOTT 223
    • 18.6.1 COMPANY SNAPSHOT 223
    • 18.6.2 REVENUE ANALYSIS 223
    • 18.6.3 PRODUCT PORTFOLIO 224
    • 18.6.4 RECENT DEVELOPMENT 224
  • 18.7 BD 225
    • 18.7.1 COMPANY SNAPSHOT 225
    • 18.7.2 REVENUE ANALYSIS 225
    • 18.7.3 PRODUCT PORTFOLIO 226
    • 18.7.4 RECENT DEVELOPMENT 226
  • 18.8 BEIJING O&D BIOTECH CO., LTD. 227
    • 18.8.1 COMPANY SNAPSHOT 227
    • 18.8.2 PRODUCT PORTFOLIO 227
    • 18.8.3 RECENT DEVELOPMENTS 227
  • 18.9 BIOMERIEUX SA 228
    • 18.9.1 COMPANY SNAPSHOT 228
    • 18.9.2 REVENUE ANALYSIS 228
    • 18.9.3 PRODUCT PORTFOLIO 229
    • 18.9.4 RECENT DEVELOPMENTS 229
  • 18.10 DIASORIN S.P.A. 230
    • 18.10.1 COMPANY SNAPSHOT 230
    • 18.10.2 REVENUE ANALYSIS 230
    • 18.10.3 PRODUCT PORTFOLIO 231
    • 18.10.4 RECENT DEVELOPMENT 231
  • 18.11 FONAR CORP. 232
    • 18.11.1 COMPANY SNAPSHOT 232
    • 18.11.2 REVENUE ANALYSIS 232
    • 18.11.3 PRODUCT PORTFOLIO 233
    • 18.11.4 RECENT DEVELOPMENTS 233
  • 18.12 GENERAL ELECTRIC 234
    • 18.12.1 COMPANY SNAPSHOT 234
    • 18.12.2 REVENUE ANALYSIS 234
    • 18.12.3 PRODUCT PORTFOLIO 235
    • 18.12.4 RECENT DEVELOPMENTS 235
  • 18.13 HOLOGIC INC. 236
    • 18.13.1 COMPANY SNAPSHOT 236
    • 18.13.2 REVENUE ANALYSIS 236
    • 18.13.3 PRODUCT PORTFOLIO 237
    • 18.13.4 RECENT DEVELOPMENT 237
  • 18.14 KONINKLIJKE PHILIPS N.V. 238
    • 18.14.1 COMPANY SNAPSHOT 238
    • 18.14.2 REVENUE ANALYSIS 238
    • 18.14.3 PRODUCT PORTFOLIO 239
    • 18.14.4 RECENT DEVELOPMENT 239
  • 18.15 MERCK KGAA. 240
    • 18.15.1 COMPANY SNAPSHOT 240
    • 18.15.2 REVENUE ANALYSIS 240
    • 18.15.3 PRODUCT PORTFOLIO 241
    • 18.15.4 RECENT DEVELOPMENT 241
  • 18.16 MEDONICA CO. LTD 242
    • 18.16.1 COMPANY SNAPSHOT 242
    • 18.16.2 PRODUCT PORTFOLIO 242
    • 18.16.3 RECENT DEVELOPMENT 242
  • 18.17 MINFOUND MEDICAL SYSTEMS CO. LTD 243
    • 18.17.1 COMPANY SNAPSHOT 243
    • 18.17.2 PRODUCT PORTFOLIO 243
    • 18.17.3 RECENT DEVELOPMENTS 244
  • 18.18 MYRIAD GENETICS, INC. 245
    • 18.18.1 COMPANY SNAPSHOT 245
    • 18.18.2 REVENUE ANALYSIS 245
    • 18.18.3 PRODUCT PORTFOLIO 246
    • 18.18.4 RECENT DEVELOPMENTS 246
Show more
  • 18.19 PLEXBIO. 247
    • 18.19.1 COMPANY SNAPSHOT 247
    • 18.19.2 PRODUCT PORTFOLIO 247
    • 18.19.3 RECENT DEVELOPMENTS 247
  • 18.20 QIAGEN 248
    • 18.20.1 COMPANY SNAPSHOT 248
    • 18.20.2 REVENUE ANALYSIS 248
    • 18.20.3 PRODUCT PORTFOLIO 249
    • 18.20.4 RECENT DEVELOPMENT 249
  • 18.21 STERNMED GMBH 250
    • 18.21.1 COMPANY SNAPSHOT 250
    • 18.21.2 PRODUCT PORTFOLIO 250
    • 18.21.3 RECENT DEVELOPMENTS 250
  • 18.22 SIEMENS HEALTHCARE GMBH 251
    • 18.22.1 COMPANY SNAPSHOT 251
    • 18.22.2 REVENUE ANALYSIS 251
    • 18.22.3 PRODUCT PORTFOLIO 252
    • 18.22.4 RECENT DEVELOPMENT 252
  • 18.23 TIME MEDICAL HOLDING. 253
    • 18.23.1 COMPANY SNAPSHOT 253
    • 18.23.2 PRODUCT PORTFOLIO 253
    • 18.23.3 RECENT DEVELOPMENT 253
  • 18.24 THERMO FISHER SCIENTIFIC INC. 254
    • 18.24.1 COMPANY SNAPSHOT 254
    • 18.24.2 REVENUE ANALYSIS 254
    • 18.24.3 PRODUCT PORTFOLIO 255
    • 18.24.4 RECENT DEVELOPMENT 255

19 QUESTIONNAIRE 256

20 RELATED REPORTS 260

LIST OF TABLES

  • TABLE 1 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 65
  • TABLE 2 ASIA PACIFIC INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 66
  • TABLE 3 ASIA PACIFIC INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 67
  • TABLE 4 ASIA PACIFIC PATHOLOGY-BASED INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 67
  • TABLE 5 ASIA PACIFIC IMAGING INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 68
  • TABLE 6 ASIA PACIFIC BIOPSY INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 69
  • TABLE 7 ASIA PACIFIC CONSUMABLES & ACCESSORIES IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 70
  • TABLE 8 ASIA PACIFIC CONSUMABLES & ACCESSORIES IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 71
  • TABLE 9 ASIA PACIFIC KITS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 71
  • TABLE 10 ASIA PACIFIC REAGENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 72
  • TABLE 11 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 76
  • TABLE 12 ASIA PACIFIC IMAGING TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 77
  • TABLE 13 ASIA PACIFIC IMAGING TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 78
  • TABLE 14 ASIA PACIFIC BLOOD TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 79
  • TABLE 15 ASIA PACIFIC BLOOD TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 80
  • TABLE 16 ASIA PACIFIC BIOPSY IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 81
  • TABLE 17 ASIA PACIFIC BIOPSY IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 81
  • TABLE 18 ASIA PACIFIC OTHERS IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 82
  • TABLE 19 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 86
  • TABLE 20 ASIA PACIFIC PAPILLARY CARCINOMA IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 87
  • TABLE 21 ASIA PACIFIC FOLLICULAR CARCINOMA IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 88
  • TABLE 22 ASIA PACIFIC OTHERS IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 89
  • TABLE 23 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 93
  • TABLE 24 ASIA PACIFIC STAGE I IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 94
  • TABLE 25 ASIA PACIFIC STAGE II IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 95
  • TABLE 26 ASIA PACIFIC STAGE III IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 96
  • TABLE 27 ASIA PACIFIC STAGE IV IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 97
  • TABLE 28 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 101
  • TABLE 29 ASIA PACIFIC 30-65 IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 102
  • TABLE 30 ASIA PACIFIC 65 AND ABOVE IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 103
  • TABLE 31 ASIA PACIFIC 21-29 IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 104
  • TABLE 32 ASIA PACIFIC BELOW 21 IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 105
  • TABLE 33 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 109
  • TABLE 34 ASIA PACIFIC HOSPITALS IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 110
  • TABLE 35 ASIA PACIFIC ASSOCIATED LABS IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 111
  • TABLE 36 ASIA PACIFIC INDEPENDENT DIAGNOSTIC LABORATORIES IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 112
  • TABLE 37 ASIA PACIFIC DIAGNOSTIC IMAGING CENTERS IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 112
  • TABLE 38 ASIA PACIFIC CANCER RESEARCH INSTITUTES IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 113
  • TABLE 39 ASIA PACIFIC OTHERS IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 114
  • TABLE 40 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 118
  • TABLE 41 ASIA PACIFIC DIRECT TENDER IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 119
  • TABLE 42 ASIA PACIFIC RETAIL SALES IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 120
  • TABLE 43 ASIA-PACIFIC THYROID CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 127
  • TABLE 44 ASIA-PACIFIC THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 127
  • TABLE 45 ASIA-PACIFIC INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 127
  • TABLE 46 ASIA-PACIFIC PATHOLOGY-BASED INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 128
  • TABLE 47 ASIA-PACIFIC IMAGING INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 128
  • TABLE 48 ASIA-PACIFIC BIOPSY INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 128
  • TABLE 49 ASIA-PACIFIC CONSUMABLES & ACCESSORIES IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 129
  • TABLE 50 ASIA-PACIFIC KITS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 129
  • TABLE 51 ASIA-PACIFIC REAGENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 129
  • TABLE 52 ASIA-PACIFIC THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 129
  • TABLE 53 ASIA-PACIFIC IMAGING TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 130
  • TABLE 54 ASIA-PACIFIC BIOPSY IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 130
  • TABLE 55 ASIA-PACIFIC BLOOD TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 130
  • TABLE 56 ASIA-PACIFIC THYROID CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 130
  • TABLE 57 ASIA-PACIFIC THYROID CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 131
  • TABLE 58 ASIA-PACIFIC THYROID CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 131
  • TABLE 59 ASIA-PACIFIC THYROID CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 131
  • TABLE 60 ASIA-PACIFIC THYROID CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 131
  • TABLE 61 JAPAN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 132
  • TABLE 62 JAPAN INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 132
  • TABLE 63 JAPAN PATHOLOGY-BASED INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 132
  • TABLE 64 JAPAN IMAGING INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 133
  • TABLE 65 JAPAN BIOPSY INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 133
  • TABLE 66 JAPAN CONSUMABLES & ACCESSORIES IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 133
  • TABLE 67 JAPAN KITS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 134
  • TABLE 68 JAPAN REAGENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 134
  • TABLE 69 JAPAN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 134
  • TABLE 70 JAPAN IMAGING TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 134
  • TABLE 71 JAPAN BIOPSY IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 135
  • TABLE 72 JAPAN BLOOD TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 135
  • TABLE 73 JAPAN THYROID CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 135
  • TABLE 74 JAPAN THYROID CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 135
  • TABLE 75 JAPAN THYROID CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 136
  • TABLE 76 JAPAN THYROID CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 136
  • TABLE 77 JAPAN THYROID CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 136
  • TABLE 78 CHINA THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 137
  • TABLE 79 CHINA INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 137
  • TABLE 80 CHINA PATHOLOGY-BASED INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 137
  • TABLE 81 CHINA IMAGING INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 138
  • TABLE 82 CHINA BIOPSY INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 138
  • TABLE 83 CHINA CONSUMABLES & ACCESSORIES IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 138
  • TABLE 84 CHINA KITS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 139
  • TABLE 85 CHINA REAGENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 139
  • TABLE 86 CHINA THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 139
  • TABLE 87 CHINA IMAGING TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 140
  • TABLE 88 CHINA BIOPSY IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 140
  • TABLE 89 CHINA BLOOD TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 140
  • TABLE 90 CHINA THYROID CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 141
  • TABLE 91 CHINA THYROID CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 141
  • TABLE 92 CHINA THYROID CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 141
  • TABLE 93 CHINA THYROID CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 141
  • TABLE 94 CHINA THYROID CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 142
  • TABLE 95 SOUTH KOREA THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 143
  • TABLE 96 SOUTH KOREA INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 143
  • TABLE 97 SOUTH KOREA PATHOLOGY-BASED INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 143
  • TABLE 98 SOUTH KOREA IMAGING INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 144
  • TABLE 99 SOUTH KOREA BIOPSY INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 144
  • TABLE 100 SOUTH KOREA CONSUMABLES & ACCESSORIES IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 144
  • TABLE 101 SOUTH KOREA KITS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 144
  • TABLE 102 SOUTH KOREA REAGENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 145
  • TABLE 103 SOUTH KOREA THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 145
  • TABLE 104 SOUTH KOREA IMAGING TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 145
  • TABLE 105 SOUTH KOREA BIOPSY IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 146
  • TABLE 106 SOUTH KOREA BLOOD TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 146
  • TABLE 107 SOUTH KOREA THYROID CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 146
  • TABLE 108 SOUTH KOREA THYROID CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 146
  • TABLE 109 SOUTH KOREA THYROID CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 147
  • TABLE 110 SOUTH KOREA THYROID CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 147
  • TABLE 111 SOUTH KOREA THYROID CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 147
  • TABLE 112 INDIA THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 148
  • TABLE 113 INDIA INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 148
  • TABLE 114 INDIA PATHOLOGY-BASED INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 148
  • TABLE 115 INDIA IMAGING INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 149
  • TABLE 116 INDIA BIOPSY INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 149
  • TABLE 117 INDIA CONSUMABLES & ACCESSORIES IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 149
  • TABLE 118 INDIA KITS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 150
  • TABLE 119 INDIA REAGENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 150
  • TABLE 120 INDIA THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 150
  • TABLE 121 INDIA IMAGING TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 150
  • TABLE 122 INDIA BIOPSY IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 151
  • TABLE 123 INDIA BLOOD TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 151
  • TABLE 124 INDIA THYROID CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 151
  • TABLE 125 INDIA THYROID CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 151
  • TABLE 126 INDIA THYROID CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 152
  • TABLE 127 INDIA THYROID CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 152
  • TABLE 128 INDIA THYROID CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 152
  • TABLE 129 THAILAND THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 153
  • TABLE 130 THAILAND INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 153
  • TABLE 131 THAILAND PATHOLOGY-BASED INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 153
  • TABLE 132 THAILAND IMAGING INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 154
  • TABLE 133 THAILAND BIOPSY INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 154
  • TABLE 134 THAILAND CONSUMABLES & ACCESSORIES IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 154
  • TABLE 135 THAILAND KITS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 155
  • TABLE 136 THAILAND REAGENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 155
  • TABLE 137 THAILAND THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 155
  • TABLE 138 THAILAND IMAGING TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 156
  • TABLE 139 THAILAND BIOPSY IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 156
  • TABLE 140 THAILAND BLOOD TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 156
  • TABLE 141 THAILAND THYROID CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 156
  • TABLE 142 THAILAND THYROID CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 157
  • TABLE 143 THAILAND THYROID CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 157
  • TABLE 144 THAILAND THYROID CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 157
  • TABLE 145 THAILAND THYROID CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 157
  • TABLE 146 SINGAPORE THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 158
  • TABLE 147 SINGAPORE INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 158
  • TABLE 148 SINGAPORE PATHOLOGY-BASED INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 158
  • TABLE 149 SINGAPORE IMAGING INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 159
  • TABLE 150 SINGAPORE BIOPSY INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 159
  • TABLE 151 SINGAPORE CONSUMABLES & ACCESSORIES IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 159
  • TABLE 152 SINGAPORE KITS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 160
  • TABLE 153 SINGAPORE REAGENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 160
  • TABLE 154 SINGAPORE THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 160
  • TABLE 155 SINGAPORE IMAGING TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 161
  • TABLE 156 SINGAPORE BIOPSY IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 161
  • TABLE 157 SINGAPORE BLOOD TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 161
  • TABLE 158 SINGAPORE THYROID CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 161
  • TABLE 159 SINGAPORE THYROID CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 162
  • TABLE 160 SINGAPORE THYROID CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 162
  • TABLE 161 SINGAPORE THYROID CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 162
  • TABLE 162 SINGAPORE THYROID CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 162
  • TABLE 163 INDONESIA THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 163
  • TABLE 164 INDONESIA INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 163
  • TABLE 165 INDONESIA PATHOLOGY-BASED INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 163
  • TABLE 166 INDONESIA IMAGING INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 164
  • TABLE 167 INDONESIA BIOPSY INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 164
  • TABLE 168 INDONESIA CONSUMABLES & ACCESSORIES IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 164
  • TABLE 169 INDONESIA KITS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 165
  • TABLE 170 INDONESIA REAGENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 165
  • TABLE 171 INDONESIA THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 165
  • TABLE 172 INDONESIA IMAGING TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 166
  • TABLE 173 INDONESIA BIOPSY IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 166
  • TABLE 174 INDONESIA BLOOD TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 166
  • TABLE 175 INDONESIA THYROID CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 166
  • TABLE 176 INDONESIA THYROID CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 167
  • TABLE 177 INDONESIA THYROID CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 167
  • TABLE 178 INDONESIA THYROID CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 167
  • TABLE 179 INDONESIA THYROID CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 167
  • TABLE 180 MALAYSIA THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 168
  • TABLE 181 MALAYSIA INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 168

LIST OF FIGURES

  • FIGURE 1 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET: SEGMENTATION 29
  • FIGURE 2 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET: DATA TRIANGULATION 32
  • FIGURE 3 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET: DROC ANALYSIS 33
  • FIGURE 4 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET: ASIA PACIFIC VS REGIONAL MARKET ANALYSIS 34
  • FIGURE 5 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS 34
  • FIGURE 6 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS 36
  • FIGURE 7 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID 37
  • FIGURE 8 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET: MARKET TESTING TYPE COVERAGE GRID 39
  • FIGURE 9 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET: VENDOR SHARE ANALYSIS 40
  • FIGURE 10 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET: SEGMENTATION 44
  • FIGURE 11 THE INCREASE IN THE AWARENESS ABOUT THYROID CANCER IS EXPECTED TO DRIVE THE ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET IN THE FORECAST PERIOD 45
  • FIGURE 12 PRODUCT TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET IN 2023 & 2030 45
  • FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET 53
  • FIGURE 14 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, 2022 61
  • FIGURE 15 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, 2023-2030 (USD MILLION) 62
  • FIGURE 16 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, CAGR (2023-2030) 62
  • FIGURE 17 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, LIFELINE CURVE 63
  • FIGURE 18 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET: BY TEST TYPE, 2022 72
  • FIGURE 19 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET: BY TEST TYPE, 2023-2030 (USD MILLION) 73
  • FIGURE 20 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET: BY TEST TYPE, CAGR (2023-2030) 73
  • FIGURE 21 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET: BY TEST TYPE, LIFELINE CURVE 74
  • FIGURE 22 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, 2022 82
  • FIGURE 23 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, 2023-2030 (USD MILLION) 83
  • FIGURE 24 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, CAGR (2023-2030) 83
  • FIGURE 25 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, LIFELINE CURVE 84
  • FIGURE 26 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET: BY STAGES, 2022 89
  • FIGURE 27 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET: BY STAGES, 2023-2030 (USD MILLION) 90
  • FIGURE 28 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET: BY STAGES, CAGR (2023-2030) 90
  • FIGURE 29 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET: BY STAGES, LIFELINE CURVE 91
  • FIGURE 30 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET: BY AGE GROUP, 2022 97
  • FIGURE 31 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET: BY AGE GROUP, 2023-2030 (USD MILLION) 98
  • FIGURE 32 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET: BY AGE GROUP, CAGR (2023-2030) 98
  • FIGURE 33 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET: BY AGE GROUP, LIFELINE CURVE 99
  • FIGURE 34 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET: BY END USER, 2022 105
  • FIGURE 35 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET: BY END USER, 2023-2030 (USD MILLION) 106
  • FIGURE 36 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET: BY END USER, CAGR (2023-2030) 106
  • FIGURE 37 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET: BY END USER, LIFELINE CURVE 107
  • FIGURE 38 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2022 114
  • FIGURE 39 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION) 115
  • FIGURE 40 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030) 115
  • FIGURE 41 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 116
  • FIGURE 42 ASIA-PACIFIC THYROID CANCER DIAGNOSTICS MARKET: SNAPSHOT (2022) 121
  • FIGURE 43 ASIA-PACIFIC THYROID CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022) 123
  • FIGURE 44 ASIA-PACIFIC THYROID CANCER DIAGNOSTICS MARKET: BY COUNTRY (2023 & 2030) 123
  • FIGURE 45 ASIA-PACIFIC THYROID CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022 & 2030) 124
  • FIGURE 46 ASIA-PACIFIC THYROID CANCER DIAGNOSTICS MARKET: PRODUCT TYPE (2023-2030) 124
  • FIGURE 47 ASIA PACIFIC THYROID CANCER DIAGNOSTICS MARKET: COMPANY SHARE 2022 (%) 188
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!